APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cyclizine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173981880319 December 2025192 pages

Choose your research edition.

Industry ResearchCyclizine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclizine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cyclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclizine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclizine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cyclizine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclizine include Teva, Glaxosmithkline, Wockhardt UK, Wabosan Arzneimittel, Pharmascript Limited, P and D Pharmaceuticals, Be-Tabs Pharmaceuticals, Aspen Pharmacare and Amoun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyclizine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyclizine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyclizine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyclizine market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyclizine Segment by Company

Teva

Glaxosmithkline

Wockhardt UK

Wabosan Arzneimittel

Pharmascript Limited

P and D Pharmaceuticals

Be-Tabs Pharmaceuticals

Aspen Pharmacare

Amoun Pharmaceutical

Amco

Aft Pharmaceuticals

Advanz Pharma

Cyclizine Segment by Type

Oral

Injection

Cyclizine Segment by Application

Migraine

Motion Sickness

Cyclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyclizine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cyclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cyclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cyclizine Industry Trends Table 2. Cyclizine Industry Drivers Table 3. Cyclizine Industry Opportunities and Challenges Table 4. Cyclizine Industry Restraints Table 5. Global Cyclizine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyclizine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cyclizine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cyclizine Sales Market Share by Manufacturers Table 9. Global Cyclizine Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cyclizine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyclizine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyclizine Manufacturers, Product Type & Application Table 13. Global Cyclizine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyclizine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Cyclizine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cyclizine Sales by Type (2021-2026) & (K Units) Table 20. Global Cyclizine Sales by Type (2027-2032) & (K Units) Table 21. Global Cyclizine Sales Market Share by Type (2021-2026) Table 22. Global Cyclizine Sales Market Share by Type (2027-2032) Table 23. Global Cyclizine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cyclizine Revenue by Type (2021-2026) & (K Units) Table 25. Global Cyclizine Revenue by Type (2027-2032) & (K Units) Table 26. Global Cyclizine Revenue Market Share by Type (2021-2026) Table 27. Global Cyclizine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Migraine Table 29. Major Manufacturers of Motion Sickness Table 30. Global Cyclizine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Cyclizine Sales by Application (2021-2026) & (K Units) Table 32. Global Cyclizine Sales by Application (2027-2032) & (K Units) Table 33. Global Cyclizine Sales Market Share by Application (2021-2026) Table 34. Global Cyclizine Sales Market Share by Application (2027-2032) Table 35. Global Cyclizine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Cyclizine Revenue by Application (2021-2026) & (K Units) Table 37. Global Cyclizine Revenue by Application (2027-2032) & (K Units) Table 38. Global Cyclizine Revenue Market Share by Application (2021-2026) Table 39. Global Cyclizine Revenue Market Share by Application (2027-2032) Table 40. Global Cyclizine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Cyclizine Sales by Region (2021-2026) & (K Units) Table 42. Global Cyclizine Sales Market Share by Region (2021-2026) Table 43. Global Cyclizine Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Cyclizine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Cyclizine Sales by Country (2021-2026) & (K Units) Table 47. North America Cyclizine Sales by Country (2027-2032) & (K Units) Table 48. Europe Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Cyclizine Sales by Country (2021-2026) & (K Units) Table 50. Europe Cyclizine Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Cyclizine Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Cyclizine Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Cyclizine Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Cyclizine Sales by Country (2027-2032) & (K Units) Table 57. Global Cyclizine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Cyclizine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Cyclizine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Cyclizine Revenue Market Share by Region (2021-2026) Table 61. Global Cyclizine Revenue Market Share by Region (2027-2032) Table 62. Teva Company Information Table 63. Teva Business Overview Table 64. Teva Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Teva Cyclizine Product Portfolio Table 66. Teva Recent Development Table 67. Glaxosmithkline Company Information Table 68. Glaxosmithkline Business Overview Table 69. Glaxosmithkline Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Glaxosmithkline Cyclizine Product Portfolio Table 71. Glaxosmithkline Recent Development Table 72. Wockhardt UK Company Information Table 73. Wockhardt UK Business Overview Table 74. Wockhardt UK Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Wockhardt UK Cyclizine Product Portfolio Table 76. Wockhardt UK Recent Development Table 77. Wabosan Arzneimittel Company Information Table 78. Wabosan Arzneimittel Business Overview Table 79. Wabosan Arzneimittel Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Wabosan Arzneimittel Cyclizine Product Portfolio Table 81. Wabosan Arzneimittel Recent Development Table 82. Pharmascript Limited Company Information Table 83. Pharmascript Limited Business Overview Table 84. Pharmascript Limited Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Pharmascript Limited Cyclizine Product Portfolio Table 86. Pharmascript Limited Recent Development Table 87. P and D Pharmaceuticals Company Information Table 88. P and D Pharmaceuticals Business Overview Table 89. P and D Pharmaceuticals Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. P and D Pharmaceuticals Cyclizine Product Portfolio Table 91. P and D Pharmaceuticals Recent Development Table 92. Be-Tabs Pharmaceuticals Company Information Table 93. Be-Tabs Pharmaceuticals Business Overview Table 94. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Be-Tabs Pharmaceuticals Cyclizine Product Portfolio Table 96. Be-Tabs Pharmaceuticals Recent Development Table 97. Aspen Pharmacare Company Information Table 98. Aspen Pharmacare Business Overview Table 99. Aspen Pharmacare Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Aspen Pharmacare Cyclizine Product Portfolio Table 101. Aspen Pharmacare Recent Development Table 102. Amoun Pharmaceutical Company Information Table 103. Amoun Pharmaceutical Business Overview Table 104. Amoun Pharmaceutical Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Amoun Pharmaceutical Cyclizine Product Portfolio Table 106. Amoun Pharmaceutical Recent Development Table 107. Amco Company Information Table 108. Amco Business Overview Table 109. Amco Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Amco Cyclizine Product Portfolio Table 111. Amco Recent Development Table 112. Aft Pharmaceuticals Company Information Table 113. Aft Pharmaceuticals Business Overview Table 114. Aft Pharmaceuticals Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Aft Pharmaceuticals Cyclizine Product Portfolio Table 116. Aft Pharmaceuticals Recent Development Table 117. Advanz Pharma Company Information Table 118. Advanz Pharma Business Overview Table 119. Advanz Pharma Cyclizine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Advanz Pharma Cyclizine Product Portfolio Table 121. Advanz Pharma Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Cyclizine Distributors List Table 125. Cyclizine Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Cyclizine Product Image Figure 2. Global Cyclizine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclizine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclizine Sales (2021-2032) & (K Units) Figure 5. Global Cyclizine Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cyclizine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Cyclizine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cyclizine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cyclizine Sales Market Share by Type (2021-2032) Figure 13. Global Cyclizine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cyclizine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cyclizine Revenue Market Share by Type (2021-2032) Figure 16. Migraine Image Figure 17. Motion Sickness Image Figure 18. Global Cyclizine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Cyclizine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Cyclizine Sales Market Share by Application (2021-2032) Figure 21. Global Cyclizine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Cyclizine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cyclizine Revenue Market Share by Application (2021-2032) Figure 24. North America Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Cyclizine Sales Market Share by Country (2021-2032) Figure 26. U.S. Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cyclizine Sales Market Share by Country (2021-2032) Figure 31. Germany Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cyclizine Sales Market Share by Country (2021-2032) Figure 38. China Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cyclizine Sales Market Share by Country (2021-2032) Figure 46. Brazil Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Cyclizine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Cyclizine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Cyclizine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Cyclizine Revenue (2021-2032) & (US$ Million) Figure 57. North America Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Cyclizine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Cyclizine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Cyclizine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Cyclizine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Cyclizine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Migraine
  • Motion Sickness
Companies covered
  • Teva
  • Glaxosmithkline
  • Wockhardt UK
  • Wabosan Arzneimittel
  • Pharmascript Limited
  • P and D Pharmaceuticals
  • Be-Tabs Pharmaceuticals
  • Aspen Pharmacare
  • Amoun Pharmaceutical
  • Amco
  • Aft Pharmaceuticals
  • Advanz Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cyclizine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cyclizine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cyclizine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cyclizine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cyclizine Market Dynamics
  1. 2.1 Cyclizine Industry Trends
  2. 2.2 Cyclizine Industry Drivers
  3. 2.3 Cyclizine Industry Opportunities and Challenges
  4. 2.4 Cyclizine Industry Restraints
3 Cyclizine Market by Manufacturers
  1. 3.1 Global Cyclizine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cyclizine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cyclizine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyclizine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclizine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyclizine Manufacturers, Product Type & Application
  7. 3.7 Global Cyclizine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclizine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclizine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclizine Tier 1, Tier 2, and Tier 3
4 Cyclizine Market by Type
  1. 4.1 Cyclizine Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Cyclizine Sales by Type
  5. 4.2.1 Global Cyclizine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyclizine Sales by Type (2021-2032)
  7. 4.2.3 Global Cyclizine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cyclizine Revenue by Type
  9. 4.3.1 Global Cyclizine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyclizine Revenue by Type (2021-2032)
  11. 4.3.3 Global Cyclizine Revenue Market Share by Type (2021-2032)
5 Cyclizine Market by Application
  1. 5.1 Cyclizine Application Introduction
  2. 5.1.1 Migraine
  3. 5.1.2 Motion Sickness
  4. 5.2 Global Cyclizine Sales by Application
  5. 5.2.1 Global Cyclizine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cyclizine Sales by Application (2021-2032)
  7. 5.2.3 Global Cyclizine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Cyclizine Revenue by Application
  9. 5.3.1 Global Cyclizine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cyclizine Revenue by Application (2021-2032)
  11. 5.3.3 Global Cyclizine Revenue Market Share by Application (2021-2032)
6 Global Cyclizine Sales by Region
  1. 6.1 Global Cyclizine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyclizine Sales by Region (2021-2032)
  3. 6.2.1 Global Cyclizine Sales by Region (2021-2026)
  4. 6.2.2 Global Cyclizine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cyclizine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cyclizine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cyclizine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cyclizine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cyclizine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cyclizine Revenue by Region
  1. 7.1 Global Cyclizine Revenue by Region
  2. 7.1.1 Global Cyclizine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cyclizine Revenue by Region (2021-2026)
  4. 7.1.3 Global Cyclizine Revenue by Region (2027-2032)
  5. 7.1.4 Global Cyclizine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cyclizine Revenue (2021-2032)
  8. 7.2.2 North America Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cyclizine Revenue (2021-2032)
  11. 7.3.2 Europe Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cyclizine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cyclizine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cyclizine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Cyclizine Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Glaxosmithkline
  8. 8.2.1 Glaxosmithkline Company Information
  9. 8.2.2 Glaxosmithkline Business Overview
  10. 8.2.3 Glaxosmithkline Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Glaxosmithkline Cyclizine Product Portfolio
  12. 8.2.5 Glaxosmithkline Recent Developments
  13. 8.3 Wockhardt UK
  14. 8.3.1 Wockhardt UK Company Information
  15. 8.3.2 Wockhardt UK Business Overview
  16. 8.3.3 Wockhardt UK Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wockhardt UK Cyclizine Product Portfolio
  18. 8.3.5 Wockhardt UK Recent Developments
  19. 8.4 Wabosan Arzneimittel
  20. 8.4.1 Wabosan Arzneimittel Company Information
  21. 8.4.2 Wabosan Arzneimittel Business Overview
  22. 8.4.3 Wabosan Arzneimittel Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Wabosan Arzneimittel Cyclizine Product Portfolio
  24. 8.4.5 Wabosan Arzneimittel Recent Developments
  25. 8.5 Pharmascript Limited
  26. 8.5.1 Pharmascript Limited Company Information
  27. 8.5.2 Pharmascript Limited Business Overview
  28. 8.5.3 Pharmascript Limited Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pharmascript Limited Cyclizine Product Portfolio
  30. 8.5.5 Pharmascript Limited Recent Developments
  31. 8.6 P and D Pharmaceuticals
  32. 8.6.1 P and D Pharmaceuticals Company Information
  33. 8.6.2 P and D Pharmaceuticals Business Overview
  34. 8.6.3 P and D Pharmaceuticals Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 P and D Pharmaceuticals Cyclizine Product Portfolio
  36. 8.6.5 P and D Pharmaceuticals Recent Developments
  37. 8.7 Be-Tabs Pharmaceuticals
  38. 8.7.1 Be-Tabs Pharmaceuticals Company Information
  39. 8.7.2 Be-Tabs Pharmaceuticals Business Overview
  40. 8.7.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Be-Tabs Pharmaceuticals Cyclizine Product Portfolio
  42. 8.7.5 Be-Tabs Pharmaceuticals Recent Developments
  43. 8.8 Aspen Pharmacare
  44. 8.8.1 Aspen Pharmacare Company Information
  45. 8.8.2 Aspen Pharmacare Business Overview
  46. 8.8.3 Aspen Pharmacare Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aspen Pharmacare Cyclizine Product Portfolio
  48. 8.8.5 Aspen Pharmacare Recent Developments
  49. 8.9 Amoun Pharmaceutical
  50. 8.9.1 Amoun Pharmaceutical Company Information
  51. 8.9.2 Amoun Pharmaceutical Business Overview
  52. 8.9.3 Amoun Pharmaceutical Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Amoun Pharmaceutical Cyclizine Product Portfolio
  54. 8.9.5 Amoun Pharmaceutical Recent Developments
  55. 8.10 Amco
  56. 8.10.1 Amco Company Information
  57. 8.10.2 Amco Business Overview
  58. 8.10.3 Amco Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amco Cyclizine Product Portfolio
  60. 8.10.5 Amco Recent Developments
  61. 8.11 Aft Pharmaceuticals
  62. 8.11.1 Aft Pharmaceuticals Company Information
  63. 8.11.2 Aft Pharmaceuticals Business Overview
  64. 8.11.3 Aft Pharmaceuticals Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aft Pharmaceuticals Cyclizine Product Portfolio
  66. 8.11.5 Aft Pharmaceuticals Recent Developments
  67. 8.12 Advanz Pharma
  68. 8.12.1 Advanz Pharma Company Information
  69. 8.12.2 Advanz Pharma Business Overview
  70. 8.12.3 Advanz Pharma Cyclizine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Advanz Pharma Cyclizine Product Portfolio
  72. 8.12.5 Advanz Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyclizine Value Chain Analysis
  2. 9.1.1 Cyclizine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyclizine Production Mode & Process
  6. 9.2 Cyclizine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyclizine Distributors
  9. 9.2.3 Cyclizine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst